Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort

Autor:	Johann Dreanic, Alix Portal, Belinda Tchoundjeu, Christophe Locher, Pascal Hammel, Anne Thirot Bidault, Julien Taieb, Claire Arbaud, David Tougeron, Romain Coriat, Laetitia Dahan, Olivier Dubreuil, Lysiane Marthey, Franck Bonnetain, Christelle De La Fouchardiere, Simon Pernot, Thierry Lecomte, Céline Lepère, Jean-Baptiste Bachet
Rok vydání:	2015
Předmět:	Nab-paclitaxel plus gemcitabine Cancer Research medicine.medical_specialty Chemotherapy second-line chemotherapy FOLFIRINOX business.industry medicine.medical_treatment Metastatic Pancreatic Adenocarcinoma Neutropenia medicine.disease Gastroenterology Gemcitabine Surgery Oncology Tolerability metastatic pancreatic cancer Internal medicine Clinical Study medicine Folfirinox business Prospective cohort study Survival analysis medicine.drug
Zdroj:	British Journal of Cancer
ISSN:	1532-1827 0007-0920
DOI:	10.1038/bjc.2015.328
Popis:	Background: There is currently no standard second-line treatment for metastatic pancreatic adenocarcinoma (MPA), and progression-free survival is consistently
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7a220a77b32447497756de6034b49f https://doi.org/10.1038/bjc.2015.328 Zobrazit plný text záznamu Plný text ve formátu PDF